(Q67490095)
Statements
Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study (English)
T. Lad
J. Schor
M. Mullane
R. Carroll
D. Chernicoff
R. Blough
1 reference
1 reference